Puissance Capital Management LP - TRACON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Puissance Capital Management LP ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$178,000
-91.3%
76,048
-98.3%
0.44%
-90.4%
Q3 2019$2,057,000
-34.3%
4,601,7680.0%4.59%
+49.8%
Q2 2019$3,129,000
-50.4%
4,601,7680.0%3.06%
-40.3%
Q1 2019$6,304,000
+117.5%
4,601,7680.0%5.13%
+55.0%
Q4 2018$2,899,000
-69.3%
4,601,7680.0%3.31%
-49.8%
Q3 2018$9,434,000
-24.1%
4,601,7680.0%6.58%
-29.5%
Q2 2018$12,425,000
+60.6%
4,601,768
+36.8%
9.34%
+40.1%
Q1 2018$7,735,0003,362,8316.67%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 995,000$3,134,0000.33%
NEA Management Company, LLC 2,759,217$8,692,0000.30%
Eventide Asset Management 900,000$2,835,0000.16%
QVT Financial LP 308,227$916,0000.03%
Candriam S.C.A. 143,000$450,0000.01%
Virtu Financial LLC 23,684$75,0000.00%
TWO SIGMA SECURITIES, LLC 13,352$42,0000.00%
BLUESTEIN R H & CO LLC 16,000$50,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 54,135$171,0000.00%
Alyeska Investment Group, L.P. 97,676$308,0000.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders